je.st
news
GSK buys Swiss vaccine developer for $325M
2013-05-29 18:43:57| Biotech - Topix.net
British pharma GlaxoSmithKline , which has its North American headquarters in Research Triangle Park, has acquired Swiss vaccine developer Okairos AG for about $325 million in cash.
Tags: developer
swiss
buys
vaccine
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||